Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Feb;16(5):81-84.
doi: 10.2217/fon-2019-0767. Epub 2019 Dec 24.

What does the future hold for chemotherapy with the use of lipid-based nanocarriers?

Carlotta Pucci  1 , Chiara Martinelli  1 , Gianni Ciofani  1
Affiliations
Editorial

What does the future hold for chemotherapy with the use of lipid-based nanocarriers?

Carlotta Pucci et al. Future Oncol. 2020 Feb.
No abstract available

Keywords: cancer therapy; chemotherapeutics; clinical trials; lipid nanocarriers; nanomedicine.

PubMed Disclaimer

References

    1. Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: Progress, challenges and opportunities. Nat Rev Cancer. 2017;17(1):20–37. - PMC - PubMed
    1. Barenholz Y. Doxil® - The first FDA-approved nano-drug: Lessons learned. J Control Release. 2012;160(2):117–34. - PubMed
    1. Srinivasan M, Rajabi M, Mousa S. Multifunctional Nanomaterials and Their Applications in Drug Delivery and Cancer Therapy. Nanomaterials. 2015;5(4):1690–1703. - PMC - PubMed
    1. Martinelli C, Pucci C, Ciofani G. Nanostructured carriers as innovative tools for cancer diagnosis and therapy. APL Bioeng. 2019;3(1) 011502. - PMC - PubMed
    1. Gulati M, Grover M, Singh S, Singh M. Lipophilic drug derivatives in liposomes. Int J Pharm. 1998;165(2):129–168.

Publication types